Zai Lab (ZLAB) Cash & Current Investments (2016 - 2026)
Zai Lab recorded quarterly Cash & Current Investments of $101.2 million in Q1 2026, down 87.02% quarter-over-quarter from $779.6 million in Q4 2025, and little changed year-over-year from $101.2 million in Q1 2025.
Zai Lab's Cash & Current Investments history runs 11 years deep, the most recent figure standing at $101.2 million for Q1 2026.
- In Q1 2026, Cash & Current Investments changed 0.05% year-over-year to $101.2 million; the TTM figure through Mar 2026 stood at $101.2 million (changed 0.05% YoY), while the FY2025 annual figure was $779.6 million, up 135.41% from the prior year.
- Cash & Current Investments came in at $101.2 million for Q1 2026 at Zai Lab, down from $779.6 million in the prior quarter.
- In the past five years, Cash & Current Investments ranged from a high of $1.3 billion in Q1 2022 to a low of $1.1 million in Q1 2024.
- A 5-year average of $508.9 million and a median of $331.2 million in 2024 frame the typical range for Cash & Current Investments.
- On a YoY basis, Cash & Current Investments climbed as much as 8982.05% in 2025 and fell as far as 98.81% in 2025.
- Zai Lab's Cash & Current Investments stood at $1.0 billion in 2022, then tumbled by 98.27% to $17.4 million in 2023, then jumped by 1803.21% to $331.2 million in 2024, then surged by 135.41% to $779.6 million in 2025, then plunged by 87.02% to $101.2 million in 2026.
- According to Business Quant data, Cash & Current Investments over the past three periods registered $101.2 million, $779.6 million, and $1.2 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | 2.13 Mn |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | 32.30 Mn |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | 286.70 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | 61.46 Mn |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | 2.77 Mn |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 7.25 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | 18.44 Mn |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | 8.75 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 3.01 Bn |
| 10 | Zai Lab | 19.59 Bn | 19.49 Bn | 61.30 Mn | 101.22 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 101.22 Mn |
| Dec 31, 2025 | 779.57 Mn |
| Sep 30, 2025 | 1.20 Mn |
| Jun 30, 2025 | 832.27 Mn |
| Mar 31, 2025 | 101.17 Mn |
| Dec 31, 2024 | 331.16 Mn |
| Sep 30, 2024 | 101.15 Mn |
| Jun 30, 2024 | 730.05 Mn |
| Mar 31, 2024 | 1.11 Mn |
| Dec 31, 2023 | 17.40 Mn |
| Sep 30, 2023 | 32.68 Mn |
| Jun 30, 2023 | 874.66 Mn |
| Mar 31, 2023 | 51.61 Mn |
| Dec 31, 2022 | 1.01 Bn |
| Sep 30, 2022 | 1.12 Bn |
| Jun 30, 2022 | 1.26 Bn |
| Mar 31, 2022 | 1.31 Bn |
| Dec 31, 2021 | 1.41 Bn |
| Sep 30, 2021 | 1.57 Bn |
| Jun 30, 2021 | 1.77 Bn |
| Mar 31, 2021 | 1.01 Bn |
| Dec 31, 2020 | 1.19 Bn |
| Sep 30, 2020 | 175.88 Mn |
| Jun 30, 2020 | 463.60 Mn |
| Mar 31, 2020 | 363.58 Mn |
| Dec 31, 2019 | 275.93 Mn |
| Sep 30, 2019 | 320.31 Mn |
| Jun 30, 2019 | 393.20 Mn |
| Dec 31, 2018 | 263.30 Mn |
| Jun 30, 2018 | 177.72 Mn |
| Dec 31, 2017 | 229.66 Mn |
| Dec 31, 2016 | 83.95 Mn |